Medical Devices Investors & VC Firms in France

79 firms in this list, with a median first check of $540K. 28 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Ysios Capital 26 people · Follows rounds	Barcelona	ES	Seed–Growth	$5.4M – $21.6M	+ Add to CRM
Gilde Healthcare 26 people · Follows rounds	Utrecht	NL	Seed–Late Stage	$1.1M – $55M	+ Add to CRM
Panacea Venture 22 people	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
OVNI Capital 11 people · Leads rounds	San Francisco	US	Pre-Seed–Series A	$250K – $2M	+ Add to CRM
Btomorrow Ventures 17 people	London	GB	Seed–Series C	—	+ Add to CRM
Forepont Capital Partners 24 people · Leads rounds	New York	US	Pre-Seed–Series A	—	+ Add to CRM
Big Pi Ventures 16 people · Leads rounds	Athens	GR	Seed–Growth	$540K – $3.2M	+ Add to CRM
United Founders 26 people	Senningerberg	LU	—	—	+ Add to CRM
BioMedPartners 17 people · Leads rounds	Basel	CH	Seed–Series A	$648K – $6.5M	+ Add to CRM
Invivo Capital Partners 13 people	Barcelona	ES	Pre-Seed–Series A	$2.2M – $4.3M	+ Add to CRM
Privilège Ventures 12 people · Follows rounds	Lugano	CH	Pre-Seed–Series A	$100K – $1M	+ Add to CRM
Brookstreet Equity Partners 22 people · Leads rounds	London	GB	Series A–Late Stage	—	+ Add to CRM
Boehringer Ingelheim Venture Fund 16 people	Ingelheim am Rhein	DE	Seed–Growth	$16.2M	+ Add to CRM
Capital Cell	Barcelona	ES	Pre-Seed–Series A	—	+ Add to CRM
AMR Action Fund 13 people · Leads rounds	Boston	US	Seed–Growth	—	+ Add to CRM
YZR Capital 12 people · Leads rounds	Munich	DE	Pre-Seed–Growth	—	+ Add to CRM
Pureos Bioventures 9 people	Pfäffikon	CH	Seed–Series C	—	+ Add to CRM
AEON Foundry 7 people	New York City	US	Pre-Seed–Seed	—	+ Add to CRM
TVM Capital 10 people · Leads rounds	Munich	DE	Seed–Late Stage	$1.1M – $16.2M	+ Add to CRM
Diamond Edge Ventures 10 people	San Francisco	US	Seed–Series A	—	+ Add to CRM
Aescap Life Sciences 14 people	Amsterdam	NL	Series A–Growth	—	+ Add to CRM
Elysia Capital 7 people	Turin	IT	—	—	+ Add to CRM
Novalis Biotech 7 people	Ghent	BE	Pre-Seed–Series A	—	+ Add to CRM
Vesalius Biocapital III Partners SàRL 11 people	Contern	LU	Series B–Late Stage	$10.8M	+ Add to CRM